#774USNASDAQ

AMZN

Amazon

$247.55USD

Data as of 2026-07-21

Composite Score49.8Average

≤−99

Margin of safety−158%Expensive

Fair value$96.06

Target$162.76

Loss chance61%Moderate-high

SizeMega cap

SectorConsumer Discretionary

Dividend—

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Consumer Discretionary median (n=196)

Quality
Profit margins & asset efficiency
60
Strong
Consumer Discretionary median (n=196) 48
Value
Price vs fundamentals
21
Poor
Consumer Discretionary median (n=196) 51
Growth
Revenue & earnings trajectory
64
Strong
Consumer Discretionary median (n=196) 49
Momentum
Recent price strength
47
Average
Consumer Discretionary median (n=196) 44
Health
Balance sheet & solvency
52
Average
Consumer Discretionary median (n=196) 43
Profitability
ROE, ROA, ROIC
66
Strong
Consumer Discretionary median (n=196) 50
Technical
Trend & volatility signals
73
Exceptional
Consumer Discretionary median (n=196) 47
Risk
Volatility & drawdown profile
45
Average
Consumer Discretionary median (n=196) 39

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Fair price check

6 different valuation methods each estimate what AMZNshould be worth, then we compare to today's price.

Heavily overvalued

Models suggest AMZN is far above estimated fair value

Today's price

$247.55

Median fair price

$96.06

-61% vs today's price

Of 5 methods:5 say pricey(1 outlier excluded)

EV/EBITDAOvervalued
thinks it's expensive — estimates $162.76, about 34% below today
P/E multiplesOvervalued
thinks it's expensive — estimates $155.87, about 37% below today
P/B multiplesOvervalued
thinks it's expensive — estimates $125.39, about 49% below today
Graham (defensive)Overvalued
thinks it's expensive — estimates $66.72, about 73% below today
Residual IncomeOvervalued
thinks it's expensive — estimates $54.57, about 78% below today
DCF (2-stage)Outlier
estimate looks unreliable — estimates $8.04 — likely unreliable

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $96.06
Margin of safety(vs fair value): < −99%
Max (ex-outliers): $162.76
Tangible BVPS: $38.05

Extreme DCF estimate

Median of all applicable methods (current price $247.55). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$2.66T
Revenue (TTM)	$742.78B
Net income (TTM)	$90.80B
Operating cash flow (TTM)	$148.53B
CapEx (TTM)	$7.42B
Free cash flow (TTM)CFO − CapEx	$141.11B
Total assets	$916.63B
Total liabilities	N/A
Stockholders' equity	$441.91B
Cash & equivalents	$101.82B
Shares outstanding	10.76B
EPS (basic)	$8.44
EPS (diluted)	$8.44
P/E ratio (TTM)	29.33

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-04-30
Latest period end: 2026-04-22
Filing lag: 82 days
Missing metrics: 4(total_liabilities, gross_profit, research_and_development, dividends_paid)